Asbestos exposure and serum osteopontin [13]

New England Journal of Medicine

Volumn 354, Issue 3, 2006, Pages 304-

  O'Regan, Anthony W ^a   Serlin, David ^b   Berman, Jeffrey S ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; OSTEOPONTIN; BIOLOGICAL MARKER; SIALOGLYCOPROTEIN; SPP1 PROTEIN, HUMAN;

BLOOD LEVEL; CLINICAL PRACTICE; CLINICAL RESEARCH; HUMAN; LETTER; LUNG FIBROSIS; MESOTHELIOMA; PLEURA DISEASE; PRIORITY JOURNAL; BLOOD; COHORT ANALYSIS; NOTE; OCCUPATIONAL EXPOSURE; PLEURA TUMOR;

ASBESTOS; BIOLOGICAL MARKERS; COHORT STUDIES; HUMANS; MESOTHELIOMA; OCCUPATIONAL EXPOSURE; OSTEOPONTIN; PLEURAL NEOPLASMS; SIALOGLYCOPROTEINS;

EID: 30944433409     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc053112     Document Type: Letter

References (5)

1. Pass HI, Lott D, Lonardo F, et al. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med 2005;353:1564-73.
2. O'Regan A. The role of osteopontin in lung disease. Cytokine Growth Factor Rev 2003;14:479-88.
3. Suezawa C, Kusachi S, Murakami T, et al Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function. J Lab Clin Med 2005;145:33-40.
4. Ashkar S, Weber GF, Panoutsakopoulou V, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000;287:860-4.
5. Crawford HC, Matrisian LM, Liaw L. Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo. Cancer Res 1998;58:5206-15.